Editorial board

Marisa joined the EMA in late 1994 and occupied scientific and managerial positions in the EMA Unit for Human Medicines Development and Evaluation. Deputy Head of Quality up to 2002 and of the Efficacy and Safety Sectors up to 2009, Marisa is currently Head of the Section for Scientific Support and Projects providing scientific support to the Agency core activities in transversal and multidisciplinary areas such as clinical trials statistical methodology, raw data analysis, non-clinical drug development, pharmacogenomics and nanotechnology. The Section is also in charge of the EMA the Innovation Task Force, reference group at EU and international level for innovative pharmaceuticals developments with current increasing activities on novel clinical trials designs, genomic biomarkers, combined products, nanomedicines, and synthetic biology. The section also runs the Business Pipeline activities contributing to the Agency’s preparedness toward the upcoming Marketing Authorisation submissions.